IGF1 and type 2 diabetes mellitus: 5) To what extent is AD-type neurodegeneration primarily mediated by intrinsic impairments of brain insulin/IGF signaling, versus secondary effects of peripheral organ insulin resistance diseases, e.g. T2DM?